Loading clinical trials...
Loading clinical trials...
An Observational Study Collecting Real-world Data on Patients With Chronic Kidney Disease to Assess: Early Treatment Experience, Treatment Patterns, Treatment Effectiveness, Patient Outcomes and Patient Quality of Life Through Prospective and Retrospective Data Capture
DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine clinical care.
DISCOVER CKD is an international observational cohort study in CKD patients, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine clinical care. No additional invasive clinical tests or procedures are mandated per study protocol, and all data collected/extracted is based solely on observations of disease management and treatment decisions made between the treating physicians and their patients, and is not intended to be interventional in anyway. Patients will not receive any experimental intervention or experimental treatment as a result of participating in this study. Analyses will be conducted separately for prospective and retrospective CKD cohorts (via interim reports), and then in aggregate by combining prospective and retrospective data, to the extent possible, at the end of the study.
Age
18 - 130 years
Sex
ALL
Healthy Volunteers
No
Research Site
Riverside, California, United States
Research Site
San Francisco, California, United States
Research Site
Sanford, Florida, United States
Research Site
Sebring, Florida, United States
Research Site
Plymouth, Massachusetts, United States
Research Site
Manhasset, New York, United States
Research Site
The Bronx, New York, United States
Research Site
Roseburg, Oregon, United States
Research Site
El Paso, Texas, United States
Research Site
Houston, Texas, United States
Start Date
September 11, 2019
Primary Completion Date
June 30, 2023
Completion Date
June 30, 2023
Last Updated
March 6, 2024
1,052
ACTUAL participants
Lead Sponsor
AstraZeneca
NCT07241390
NCT06926660
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06717698